We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 5

1.
Figure 1

Figure 1. Experimental design of in vivo site-specific photocrosslinking experiments. From: Recognition of an ERAD-L substrate analyzed by site-specific in vivo photocrosslinking.

(A) Schematics of the ERAD-L substrates used. (B) Explanation of the in vivo photocrosslinking method. BpA, phenylalanine derivative containing a benzophenone.

Ann Marie Stanley, et al. FEBS Lett. ;585(9):1281-1286.
2.
Figure 5

Figure 5. Photocrosslinking to Der1p. From: Recognition of an ERAD-L substrate analyzed by site-specific in vivo photocrosslinking.

(A) sCPY*-HA with a photoreactive probe at position +24 was expressed together with Der1p-13myc in cells lacking different ERAD components. After in vivo photocrosslinking, membranes were isolated and SDS-denatured proteins were immunoprecipitated with HA antibodies. The samples were analyzed by SDS-PAGE and immunoblotting with either HA or Myc antibodies. (B) Der1p-13myc crosslinking was examined in usa1Δ cells containing an empty vector or plasmids coding for the indicated segments of Usa1p. U and H, segments involved in Usa1p oligomerization and Hrd1p interaction, respectively [9].

Ann Marie Stanley, et al. FEBS Lett. ;585(9):1281-1286.
3.
Figure 4

Figure 4. Photocrosslinking of sCPY*-DHFR-HA to Yos9p. From: Recognition of an ERAD-L substrate analyzed by site-specific in vivo photocrosslinking.

(A) sCPY*-HA with amber codons at the indicated positions was expressed together with Yos9p-13myc and subjected to in vivo photocrosslinking. sCPY*-HA lacking an N-glycosylation site (unglyc) with a photoreactive probe at position +7 was also tested. Membranes were isolated and SDS-denatured proteins were immunoprecipitated with HA antibodies. The samples were analyzed by SDS-PAGE and immunoblotting with either HA or Myc antibodies. (B) sCPY*-HA with a photoreactive probe at position −69, with or without a N-glycosylation site was crosslinked to Yos9p-13myc-HDEL in wild type cells or cells lacking different ERAD components. (C) As in (B), but crosslinking was also tested when both a carbohydrate chain in the substrate and Hrd3p were absent.

Ann Marie Stanley, et al. FEBS Lett. ;585(9):1281-1286.
4.
Figure 3

Figure 3. Photocrosslinking to Hrd3p in different ERAD mutants. From: Recognition of an ERAD-L substrate analyzed by site-specific in vivo photocrosslinking.

(A) sCPY*-HA with amber codons at the indicated positions was expressed together with Hrd3p-13myc in wild type cells or cells lacking Yos9p. After in vivo photocrosslinking, membranes were isolated and SDS-denatured proteins were immunoprecipitated with HA antibodies. The samples were analyzed by SDS-PAGE and immunoblotting with either HA or Myc antibodies. The numbers underneath the lanes give the relative crosslinking efficiency. For quantification, the intensity of the myc band was divided by that of the corresponding HA band, and normalized to the ratio determined for position +7. (B) As in (A), but crosslinking in wild type cells is compared with that in cells lacking Usa1p or Hrd1p.

Ann Marie Stanley, et al. FEBS Lett. ;585(9):1281-1286.
5.
Figure 2

Figure 2. Photocrosslinking to Hrd3p. From: Recognition of an ERAD-L substrate analyzed by site-specific in vivo photocrosslinking.

(A) sCPY*-HA or sCPY*-DHFR-HA with amber codons at the indicated positions were expressed together with Hrd3p-13myc and subjected to in vivo photocrosslinking. Membranes were isolated and SDS-denatured proteins were immunoprecipitated with HA antibodies. The samples were analyzed by SDS-PAGE and immunoblotting with either HA or Myc antibodies. The numbers underneath the lanes give the relative crosslinking efficiency. For quantification, the intensity of the myc band was divided by that of the corresponding HA band, and normalized to the ratio determined for position +7. The comparison of crosslinking efficiency is only approximate, as the level of photocrosslinker incorporation may vary between positions. (B) sCPY*-HA with a photoreactive probe at position +7 was crosslinked to Hrd3p-13myc in cells lacking ERAD components. Where indicated, UV irradiation was omitted. (C) sCPY*-HA containing the N-glycosylation site (glyc) or lacking it (unglyc; mutation of N to A), both with a photoreactive probe at position +7, were crosslinked to Hrd3p-13myc. The asterisk indicates immunoglobulin light chain. (D) For comparison with (A), crosslinking to Hrd1p-13 myc was tested with sCPY*-HA or sCPY*-DHFR-HA containing a photoreactive probe at the indicated positions. The open arrows indicate the position of substrate, and the asterisk denotes non-specific bands reacting with Myc antibodies.

Ann Marie Stanley, et al. FEBS Lett. ;585(9):1281-1286.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk